Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease
Clinical trial NCT02378688 · COMPLETED
Trial details
- NCT number
- NCT02378688
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-10-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.